Philip Morris’s push into healthcare is faltering, prompting it to consider options such as selling a stake in its biggest pharmaceuticals unit.
Philip Morris’s push into healthcare is faltering, prompting it to consider options such as selling a stake in its biggest pharmaceuticals unit.